Regeneron stops enrolling critically ill COVID-19 patients for antibody drug trial | TheHill - The Hill
- Regeneron stops enrolling critically ill COVID-19 patients for antibody drug trial | TheHill The Hill
- Study finds brain abnormalities 'common' in COVID-19 patients Yahoo Lifestyle
- New COVID-19 cases continue to rise in 25 states, setting new infection records CBS This Morning
- Two coronavirus side effects that might never go away BGR
- Second study testing COVID-19 antibody reports setback KRON4
- View Full Coverage on Google News